{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05483868",
            "orgStudyIdInfo": {
                "id": "AU-011-102"
            },
            "organization": {
                "fullName": "Aura Biosciences",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer",
            "officialTitle": "A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) to Determine the Feasibility and Safety of Intratumoral Injection With or Without Intramural Injection in Subjects With Bladder Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-phase-open-label-trial-of-belzupacap-sarotalocan-au-in-bladder-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-07-20",
            "studyFirstSubmitQcDate": "2022-07-29",
            "studyFirstPostDateStruct": {
                "date": "2022-08-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-11",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Aura Biosciences",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The main objectives of this study are to determine the feasibility and safety of AU-011 treatment of bladder cancer utilizing intratumoral injection with or without intramural injection and with or without laser application.",
            "detailedDescription": "Aura is conducting a Phase 1, 'window of opportunity', open-label trial of belzupacap sarotalocan (AU-011) to determine the feasibility and safety of intratumoral injection with or without intramural injection and with or without laser application in subjects with bladder cancer."
        },
        "conditionsModule": {
            "conditions": [
                "Non-muscle-invasive Bladder Cancer",
                "Muscle-Invasive Bladder Carcinoma"
            ],
            "keywords": [
                "NMIBC",
                "Cystectomy",
                "TURBT",
                "Intramural",
                "AU-011",
                "Belzupacap Sarotalocan",
                "Intratumoral",
                "MIBC"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 21,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intratumoral and intramural injection of AU-011 prior to TURBT (1b)",
                    "type": "EXPERIMENTAL",
                    "description": "Intratumoral (50 \u03bcg) and intramural (50 \u03bcg) injection of AU-011 prior to the standard of care (TURBT) in patients with NMIBC.",
                    "interventionNames": [
                        "Drug: AU-011"
                    ]
                },
                {
                    "label": "Intratumoral and intramural injection of AU-011 with laser application before TURBT (4a)",
                    "type": "EXPERIMENTAL",
                    "description": "Intratumoral (50 \u03bcg) and intramural (50 \u03bcg) injection of AU-011 with laser application before standard of care (TURBT) in patients with NMIBC.",
                    "interventionNames": [
                        "Combination Product: AU-011 in Combination with Medical Laser Adminstration"
                    ]
                },
                {
                    "label": "Intratumoral injection of AU-011 with laser application before TURBT (4b)",
                    "type": "EXPERIMENTAL",
                    "description": "Intratumoral injection of AU-011 (100 \u03bcg) with laser application before standard of care (TURBT) in patients with NMIBC.",
                    "interventionNames": [
                        "Combination Product: AU-011 in Combination with Medical Laser Administration"
                    ]
                },
                {
                    "label": "Intratumoral injection of AU-011 with laser application before TURBT (4c)",
                    "type": "EXPERIMENTAL",
                    "description": "Intratumoral injection of AU-011 (200 \u03bcg) with laser application before standard of care (TURBT) in patients with NMIBC.",
                    "interventionNames": [
                        "Combination Product: AU-011 in Combination with Medical Laser Administration"
                    ]
                },
                {
                    "label": "AU-011 intratumoral injection with laser application prior to cystectomy (5a)",
                    "type": "EXPERIMENTAL",
                    "description": "Intratumoral injection of AU-011 (100 \u03bcg) with laser application followed by standard of care (cystectomy) in patients with NMIBC or MIBC.",
                    "interventionNames": [
                        "Combination Product: AU-011 in Combination with Medical Laser Administration"
                    ]
                },
                {
                    "label": "AU-011 intratumoral injection with laser application prior to cystectomy (5b)",
                    "type": "EXPERIMENTAL",
                    "description": "Intratumoral injection of AU-011 (200 \u03bcg) with laser application followed by standard of care (cystectomy) in patients with NMIBC or MIBC.",
                    "interventionNames": [
                        "Combination Product: AU-011 in Combination with Medical Laser Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "AU-011",
                    "description": "Administration of AU-011 intratumorally and intramurally",
                    "armGroupLabels": [
                        "Intratumoral and intramural injection of AU-011 prior to TURBT (1b)"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "AU-011 in Combination with Medical Laser Adminstration",
                    "description": "AU-011 Intratumorally and Intramurally",
                    "armGroupLabels": [
                        "Intratumoral and intramural injection of AU-011 with laser application before TURBT (4a)"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "AU-011 in Combination with Medical Laser Administration",
                    "description": "AU-011 Intratumorally",
                    "armGroupLabels": [
                        "AU-011 intratumoral injection with laser application prior to cystectomy (5a)",
                        "AU-011 intratumoral injection with laser application prior to cystectomy (5b)",
                        "Intratumoral injection of AU-011 with laser application before TURBT (4b)",
                        "Intratumoral injection of AU-011 with laser application before TURBT (4c)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety of AU-011: Incidences of SAEs and DLTs",
                    "description": "Incidence and severity of treatment-related adverse events and serious adverse events (SAEs) and incidence of dose-limiting toxicities (DLTs).",
                    "timeFrame": "56 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Confirmed diagnosis urothelial carcinoma of the bladder (Recurrence of prior NMIBC biopsy or pathology must be obtained within 12 months prior to enrollment. First time NMIBC biopsy within 6 months of screening. MIBC allowed if demonstrated pathologically)\n2. Have no evidence of metastatic disease\n3. Adequate bone marrow, renal, and hepatic function\n\nExclusion Criteria:\n\n1. Any additional malignancy that requires active treatment. Exceptions include:\n\n   1. Basal cell carcinoma of the skin, squamous cell carcinoma of the skin that has undergone potentially curative therapy with evidence of remission for at least 1 year.\n   2. In situ cervical cancer treated and with at least 1 year without recurrence.\n   3. Any other subject felt appropriate by the Investigator upon discussion with trial's Medical Monitor.\n2. Used an investigational drug or medical device within 30 days or 5 half-lives (whichever is longer) of Visit 1 or be concurrently enrolled in another investigational trial.\n3. Active bacterial, fungal, or viral infections - all prior infections must have resolved following optimal therapy and subject must be off all systemic anti-infective agents.\n4. Chronic active hepatitis B or C and HIV.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Medical Monitor",
                    "role": "CONTACT",
                    "phone": "617-500-8864",
                    "email": "clinical@aurabiosciences.com"
                }
            ],
            "locations": [
                {
                    "facility": "Arkansas Urology",
                    "status": "TERMINATED",
                    "city": "Little Rock",
                    "state": "Arkansas",
                    "zip": "72211",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.74648,
                        "lon": -92.28959
                    }
                },
                {
                    "facility": "Saint John's Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90404",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Frances Feng",
                            "role": "CONTACT",
                            "email": "mailto:frances.feng@providence.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "Montefiore Medical Center",
                    "status": "RECRUITING",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10461",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jerel Johnson",
                            "role": "CONTACT",
                            "email": "jerjohnson@montefiore.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "Carolina Urologic Research Center",
                    "status": "RECRUITING",
                    "city": "Myrtle Beach",
                    "state": "South Carolina",
                    "zip": "29272",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Sutton",
                            "role": "CONTACT",
                            "email": "jsutton@curcmb.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.68906,
                        "lon": -78.88669
                    }
                },
                {
                    "facility": "Urology Associates, P.C.",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37209",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mercedes Bruce",
                            "role": "CONTACT",
                            "email": "MBruce@ua-pc.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Mary Crowley Cancer Research",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75251",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joshua Matson",
                            "role": "CONTACT",
                            "phone": "214-658-1987",
                            "email": "jomatson@marycrowley.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Baylor College of Medicine",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sharon Harrison",
                            "role": "CONTACT",
                            "email": "sharons@bcm.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "The University of Texas San Antonio",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ahmad Abdel-Aziz",
                            "role": "CONTACT",
                            "email": "Abdelaziza1@uthscsa.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Urology San Antonio/USA Clinical Trials",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Karina Lozano",
                            "role": "CONTACT",
                            "email": "karina.lozano@usa-clinicaltrials.com"
                        },
                        {
                            "name": "Jose",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                },
                {
                    "id": "D000093284",
                    "term": "Non-Muscle Invasive Bladder Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2976",
                    "name": "Non-Muscle Invasive Bladder Neoplasms",
                    "asFound": "Non-muscle Invasive Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        }
    },
    "hasResults": false
}